Concepedia

Author

Laiq Chaudry

GlaxoSmithKline (United Kingdom)

Also Known As

L Chaudry, L. CHAUDRY, L. Chaudry, LAIQ CHAUDRY, Laiq Chaudry

15

Publications

462

Citations

10

H-Index

18

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)GlaxoSmithKline (United States)University College LondonThe Royal Free Hospital
LC

About

Laiq Chaudry is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, pharmacology, and medicinal chemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

186

2

Natural Sciences

4

4

104

3

Biochemistry

4

4

104

4

Chemical Biology

2

2

61

5

Endocrinology

2

2

82

Laiq Chaudry

×

9

Publications

422

Citations

9

H-Index

YearCitations

Discovery of GSK2795039, a Novel Small Molecule NADPH Oxidase 2 Inhibitor

Kazufumi Hirano, Woei Shin Chen, Adeline L.W. Chueng,

Antioxidants and Redox Signaling

2015

187

Release of arachidonic acid and the effects of corticosteroids on steroidogenesis in rat testis Leydig cells

B.A. Cooke, Ghenima Dirami, Laiq Chaudry,

The Journal of Steroid Biochemistry and Molecular Biology

1991

65

Factor Xa Inhibitors:  S1 Binding Interactions of a Series of <i>N</i>-{(<i>3S</i>)-1-[(<i>1S</i>)-1-Methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}sulfonamides

Chuen Chan, Alan D. Borthwick, David Brown,

Journal of Medicinal Chemistry

2007

49

Discovery of Novel Irreversible Inhibitors of Interleukin (IL)-2-inducible Tyrosine Kinase (Itk) by Targeting Cysteine 442 in the ATP Pocket

John D. Harling, Angela M. Deakin, Sébastien Campos,

Journal of Biological Chemistry

2013

32

Design and synthesis of orally active pyrrolidin-2-one-based factor Xa inhibitors

Nigel S. Watson, David Brown, Matthew Campbell,

Bioorganic & Medicinal Chemistry Letters

2006

30

Antithrombotic Potential of GW813893: A Novel, Orally Active, Active-site Directed Factor Xa Inhibitor

Melanie A Abboud, Saul Needle, Cynthia L. Burns-Kurtis,

Journal of Cardiovascular Pharmacology

2008

17

IMMUNOREACTIVE HUMAN CHORIONIC GONADOTROPHIN FROM THE CYST FLUID AND CSF OF PATIENTS WITH CRANIOPHARYNGIOMA

Philip E. Harris, L. A. Perry, T. Chard,

Clinical Endocrinology

1988

17

The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs

Nigel S. Watson, Carl Adams, David Belton,

Bioorganic & Medicinal Chemistry Letters

2011

13

Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with monoaryl P4 motifs

Savvas Kleanthous, Alan D. Borthwick, David Brown,

Bioorganic & Medicinal Chemistry Letters

2009

12

Page 1